Increases in matrix metalloproteinases (MMPs) at atherosclerotic lesions are involved in the migration of smooth muscle cells (SMCs) into the intima and to the rupture of plaques, being implicated in the progression of atherosclerosis. The present study examined the mechanisms underlying the production of MMP-1, interstitial collagenase-1, induced by oxidized low-density lipoprotein (oxLDL) and 4-hydroxynonenal (4-HNE), factors proposed to play a pivotal role in atherogenesis, in human coronary SMCs. oxLDL promoted the production of MMP-1 with the preceding phosphorylation of extracellular signal-regulated kinase (ERK) 1/2. Immunoprecipitation of platelet-derived growth factor receptor β (PDGFR-β) revealed that oxLDL induced tyrosine phosphorylation of the receptor. Inhibition of the activation of PDGFR-β and ERK1/2 resulted in a suppression of the production of MMP-1. Consistently, 4-HNE also elicited the production of MMP-1 with the preceding phosphorylation of PDGFR-β and ERK1/ 2. The 4-HNE-induced production of MMP-1 was prevented when the activation of PDGFR-β and ERK1/2 was inhibited. The present results suggest that the activation of PDGFR-β and ERK1/2 is involved in the production of MMP-1 in oxLDL-and 4-HNE-stimulated human coronary SMCs.
Introduction
Atherosclerosis develops and progresses in association with the oxidation of low-density lipoprotein (LDL) and the accumulation of the oxidized LDL (oxLDL) within the arterial wall [1, 2] . oxLDL triggers numerous biological responses including the transformation of macrophages into lipid-laden foam cells and the migration of vascular smooth muscle cells (SMCs) into the intima [3] [4] [5] . These oxLDL-promoted cellular responses lead to the accumulation and subsequent necrosis of foam cells followed by the development of a lipid core, and to the formation of fibrous caps composed of intimal SMCs and extracellular matrix components to cover the lipid core, resulting in the formation of atherosclerotic plaques. In the advanced stages of atherosclerosis, the thickness of the fibrous caps decreases with the degradation of components of the extracellular matrix, leading to the formation of vulnerable plaques that are susceptible to rupture. The disruption of the plaques triggers the formation of a thrombus, which is the cause of acute coronary syndromes [4] [5] [6] . Thus, oxLDL plays a critical role in atherogenesis. The biological activities of oxLDL are in part mediated by various components present in oxLDL particles including oxysterols, lysophosphatidylcholine, oxidized phospholipids, and aldehydes such as 4-hydroxynonenal (4-HNE) [7] [8] [9] .
During the course of atherosclerosis, the migration of SMCs and the rupture of plaques are associated with the degradation of extracellular matrix proteins, such as collagen and fibronectin, catalyzed by matrix metalloproteinases (MMPs) [6, [10] [11] [12] . The more than 20 types of MMPs identified to date have been classified into groups including collagenases (MMP-1, -8, and -13), gelatinases (MMP-2 and -9), stromelysins (MMP-3, -10, and -11), membrane-type MMPs (MMP- 14, -15, -16, -17, -24, and -25) , and matrilysins (MMP-7 and -26) [13] . The expression of MMP-1, -2, -3, -7, -8, -9, -13, and -14 is increased at atherosclerotic lesions including the shoulder region of vulnerable plaques in human and animal models [10, [14] [15] [16] [17] [18] . Among the MMPs, collagenases cleave native collagen types I and III, predominant structural components of atherosclerotic lesions, while other MMPs, such as gelatinases, can degrade the collagenase-generated fragments only, indicating that an increase in collagenases is a critical event in the progression of atherosclerosis.
In atherosclerotic lesions, MMP-1 localizes mainly with SMCs [14, 15] and macrophages [14, 16] while MMP-8 and -13 are expressed by neutrophils [17] and macrophages [16] , respectively. Several cytokines have been shown to stimulate the expression of MMP-1 in SMCs and macrophages [19] [20] [21] [22] . However, little is known about the contribution of oxLDL and bioactive oxidized lipids including 4-HNE to the production of MMP-1, although oxLDL is reported to increase MMP-1 levels in human umbilical vein and aortic endothelial cells [23] , MMP-9 levels in human monocyte-derived macrophages [24] , and MMP-14 levels in human saphenous vein SMCs [25] . In the present study, therefore, we examined the possible involvement of oxLDL and 4-HNE in the production of MMP-1 and the intracellular signaling responsible for the production in human coronary SMCs (hCSMCs).
Materials and methods

Materials
Antibodies against extracellular signal-regulated kinase (ERK) 1/2, phosphorylated ERK1/2, platelet-derived growth factor receptor β (PDGFR-β, sc-432), and phosphorylated tyrosine residue of PDGFR-β (sc-17173), and protein A-agarose were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). The antibody against platelet-derived growth factor (PDGF) BB and/or AA (Catalog number, AB-20-NA; Lot number, N09) was from R&D Systems, Inc. (Minneapolis, MN). PD98059, 4-HNE, AG1295, and AG1478 were from Calbiochem (La Jolla, CA). Human native LDL (BT-903) was from Biomedical Technologies Inc. (Stoughton, MI), the anti-MMP-1 antibody was from Sigma (St. Louis, MO), and 2′,7′-dichlorodihydrofluorescein (DCFH) diacetate was from Molecular Probes, Inc. (Eugene, OR). All other reagents were obtained from Wako Pure Chemical Industries (Osaka, Japan).
Cell culture
hCSMCs (Cambrex Bio Science Walkersville, Inc., Walkersville, MD) were cultured in MCDB131 medium supplemented with 5% heat-inactivated fetal bovine serum, 1 ng/ml basic fibroblast growth factor, 0.5 ng/ml epidermal growth factor, 5 μg/ml insulin, 100 units/ml penicillin, and 100 μg/ ml streptomycin in collagen (type I)-coated culture dishes (Asahi Techno Glass, Corp. Japan). The cells, between the 6th and 8th passages, were plated in 35-mm dishes at 2 × 10 5 cells in MCDB131 medium, and placed in fresh medium.
Preparation of oxLDL
The oxidation of LDL was performed as described previously [26] . Briefly, human native LDL (2.5 mg protein/ml) was oxidized with 10 μM CuSO 4 at 37°C for 3 h, and dialyzed against phosphate-buffered saline containing 200 μM EDTA at 4°C. The oxLDL contained 10-15 nmol thiobarbituric acidreactive substances (TBARS)/mg protein, while native LDL (before oxidation) contained 0.6-1.2 nmol TBARS/mg protein. The relative electrophoretic mobility of the oxLDL was about 1.4 as compared with that of native LDL.
Immunoblot analysis
hCSMCs were treated and stimulated with various reagents including oxLDL and 4-HNE, as described in the figure legends. The extracellular medium and cells, as samples, were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis on a 10% gel. The separated proteins were transferred onto a nitrocellulose membrane. Antibodies against MMP-1, ERK1/2, and phosphorylated ERK1/2 were applied. The bound antibodies were visualized using a peroxidase-conjugated secondary antibody and enhanced chemiluminescence Western blotting detection reagents (Amersham Pharmacia Biotech). Representative results of three separate experiments are shown. To estimate the amounts of MMP-1, the density of each band on a film was analyzed using a film scanner and NIH image analysis software. The results are expressed in arbitrary units (mean ± SEM, n = 3).
Immunoprecipitation of PDGFR-β
hCSMCs were incubated with genistein or AG1295 for 1 h in the presence of 5 mM Na 3 VO 4 , and stimulated with oxLDL or 4-HNE as described in the figure legends. After being washed, the cells were lysed and subjected to immunoprecipitation of PDGFR-β as described previously [27] . The lysate was incubated with anti-PDGFR-β antibodies overnight at 4°C and further with protein A-agarose for 3 h. After centrifugation, the pellet was subjected to immunoblot analysis (a 5% gel) using antibodies against PDGFR-β or the phosphorylated tyrosine residue of PDGFR-β. Representative results of three separate experiments are shown. To estimate the phosphorylation of PDGFR-β, the density of the bands for PDGFR-β and its phosphorylated form on a film was analyzed as above. Results are adjusted for PDGFR-β levels and expressed in arbitrary units (mean ± SEM, n = 3).
Zymography and collagenase activity
After stimulation with oxLDL, the extracellular medium was subjected to zymography to detect MMP-1 using a casein (1 mg/ml)-containing 12% Zymogram Gel (Invitrogen). Zymography was carried out by treatment of the gel with NOVEX Zymogram renaturing buffer and NOVEX Zymogram developing buffer (Invitrogen). The gel was stained with Coomassie Brilliant Blue R-250. Collagenase activity was determined with FITC-labeled collagen (type I) as a fluorogenic substrate using a commercial assay kit (Cosmo Bio, Japan). Briefly, the extracellular medium was treated with 0.9 mM 4-aminophenylmercuric acetate at 37°C for 10 min to activate MMP-1, and further incubated with the substrate for 3 h. After centrifugation of the mixture, the fluorescence intensity in the supernatant was measured with a spectrofluorometer (F-2000, Hitachi), with excitation at 495 nm and emission at 520 nm. One unit of the enzymatic activity represents the degradation of 1 μg of collagen per min.
Reverse transcription-polymerase chain reaction (RT-PCR)
The expression of transcripts for MMP-1 was analyzed by RT-PCR. After stimulation of hCSMCs with oxLDL, total RNAwas extracted from the cells with ISOGEN (NIPPON GENE Co., Ltd., Tokyo, Japan). First-strand cDNA was generated from the total RNA in a reaction mixture containing random ninemers, dNTP, RNase inhibitor, and ReverTra Ace (TOYOBO, Co. Ltd., Osaka, Japan). The resulting reaction mixture was subjected to PCR with AmpliTaq Gold (Applied Biosystems) using the following primers: 5′-GATCATCGGGA-CAACTCTCCT (sense) and 5′-TCCGGGTAGAAGGGATTTGTG (antisense) for MMP-1, 5′-CAAGACCAGGACGGTCATTT (sense) and 5′-ACATC-CATGTCCCAGGAAAG (antisense) for PDGF-AA, 5′-CGAGTTGGACCT-GAACATGA (sense) and 5′-GTCACCGTGGCCTTCTTAAA (antisense) for PDGF-BB, and 5′-GATCATTGCTCCTCCTGAGC (sense) and 5′-CACCTT-CACCGTTCCAGTTT (antisense) for β-actin. The PCR conditions were as follows: a denaturing step at 94°C for 10 min; followed by 30 cycles of 95°C for 60 s, 56°C for 60 s, and 72°C for 150 s. Products (434 bp for MMP-1, 408 bp for PDGF-AA, 339 bp for PDGF-BB and 308 bp for β-actin) were resolved on 1.5% agarose gels and visualized with ethidium bromide.
Measurement of the generation of reactive oxygen species (ROS)
hCSMCs were treated with N-acetylcysteine for 24 h and washed. The cells were treated with DCFH diacetate (20 μM), as a probe, at 37°C for 30 min. After being washed, cells were stimulated with oxLDL for 30 min, collected, and resuspended in Hanks' solution. The fluorescence of 2′,7′-dichlorofluorescein resulting from DCFH oxidation was measured with a flow cytometer (FACSCalibur with CellQuest software, Becton-Dickson Biosciences). The generation of ROS was expressed as the mean fluorescence intensity of 10,000 cells determined in each sample.
Results
The stimulation of hCSMCs with oxLDL (50 μg/ml) for 6-24 h time-dependently induced an increase in MMP-1 protein in the extracellular medium, as estimated by immunoblotting, as shown in Fig. 1A . The oxLDL-promoted production of MMP-1 occurred in a dose-dependent manner (10-50 μg/ml), as confirmed by immunoblotting and zymography and by an assay for collagenase activity ( Fig. 1B and C) . In comparison with oxLDL, native LDL (20 or 50 μg/ml) had a little effect on the production of MMP-1 in hCSMCs ( Fig. 1D ). Under our experimental conditions, there was no significant difference between amounts of protein recovered from each dish (2 × 10 5 cells): for example, 141 ± 3.2 and 142 ± 2.8 μg/dish (mean ± SEM, n = 3), control and oxLDL at 24 h ( Fig. 1A) , respectively; 138 ± 4, 142 ± 4, 137 ± 3, and 139 ± 3 μg/dish (mean ± range, n = 2), control, 20 μg/ml native LDL, 50 μg/ml native LDL, and oxLDL ( Fig. 1D ), respectively.
The induction of MMP-1 gene expression is suggested to be mediated by ERK1/2 in canine fibroblast-like synoviocytes stimulated with basic calcium phosphate crystals [28] . To define the intracellular signaling responsible for the oxLDLinduced production of MMP-1, the possible involvement of ERK1/2 was examined ( Fig. 2 ). Stimulation with oxLDL (50 μg/ml) for 5-20 min resulted in an increase in phosphorylated ERK1/2. The oxLDL (50 μg/ml, for 10 min)-induced phosphorylation of ERK1/2 was suppressed dose-dependently by pretreatment with PD98059 (1-10 μM), an inhibitor of mitogen-activated protein kinase/ERK kinase. Under the conditions, the oxLDL-induced production of MMP-1 was also prevented in a manner dependent on the concentration of PD98059, suggesting that the production of MMP-1 depends on the activation of ERK1/2.
The activation of ERK1/2 is triggered by the stimulation of receptors for growth factors such as PDGFR-β in a variety of cell types including SMCs [29, 30] . Since oxLDL has been shown to induce the activation of PDGFR-β in rabbit arterial SMCs [31] , we examined its involvement in the oxLDL-induced production of MMP-1 in hCSMCs. Fig. 3A showed that stimulation with oxLDL (50 μg/ml) for 5-20 min resulted in an increase in tyrosine-phosphorylated PDGFR-β with a maximal response 10 min after the stimulation, as estimated by immunoprecipitation of PDGFR-β and immunoblotting using antibodies against PDGFR-β bearing a phospho-tyrosine residue. However, native LDL (50 μg/ml, for 10 min) was less effective than oxLDL (Fig.  3B ). The oxLDL (50 μg/ml, for 10 min)-induced phosphorylation of PDGFR-β was almost completely suppressed by pretreatment with genistein (20 μM), an inhibitor of protein tyrosine kinase (Fig. 3C ). Genistein (20 μM) markedly inhibited the oxLDL-induced increase in MMP-1 protein and phosphorylation of ERK1/2 (Fig. 4, A and B) . However, genistein even at 20 μM did not affect the phosphorylation of ERK1/2 (Fig. 4B) or the production of MMP-1 (data not shown) induced by phorbol 12-myristate 13-acetate (100 nM), a protein kinase C activator, which activates ERK1/2 independently of the activation of receptors [32] , indicating that genistein had no effect on the pathways responsible for the ERK1/2-mediated production of MMP-1. Furthermore, as shown in Fig. 4C , AG1295 (20-100 μM), a specific inhibitor of tyrosine kinase of PDGFR, dose-dependently suppressed the oxLDL-induced production of MMP-1, while AG1478 (250 or 500 nM), an inhibitor of tyrosine kinase of epidermal growth factor receptor, had no effect (Fig. 4D) . We further observed that pretreatment of oxLDL with the antibodies against PDGF (50 μg/ml) did not affect the production of MMP-1 induced by the oxLDL (Fig.   Fig. 1 . Promotion of the production of MMP-1 by oxLDL. (A) hCSMCs were stimulated with (+) or without (−) oxLDL (50 μg/ml) for the indicated periods. MMP-1 in the extracellular medium was analyzed by immunoblotting. (B) hCSMCs were stimulated with various concentrations of oxLDL (10-50 μg/ml) for 24 h. MMP-1 in the extracellular medium was analyzed by immunoblotting (a) and zymography (b). (C) Collagenase activity was measured in the extracellular medium of the cells stimulated with oxLDL as in panel B. (D) hCSMCs were stimulated with or without native LDL (nLDL, 20 or 50 μg/ml) or oxLDL (50 μg/ml) for 24 h. MMP-1 in the extracellular medium was analyzed by immunoblotting. 4E). These findings suggest that the activation of PDGFR-β is involved in the promotion of MMP-1 production induced by oxLDL.
oxLDL has been shown to induce the production of PDGF-AA in canine SMCs prepared from prosthetic vascular grafts but not in canine aortic SMCs [33] . In the present study, oxLDL (50 μg/ml) promoted the expression of MMP-1 mRNA, but did not affect the expression of PDGF-AA mRNA or PDGF-BB mRNA in hCSMCs (Fig. 5A ). Furthermore, although hCSMCs were stimulated with oxLDL (50 μg/ml) in the presence of antibodies against PDGF (100 μg/ml), the oxLDL-induced production of MMP-1 was not affected as estimated by zymography ( Fig. 5B) . As a control experiment, the antibodies impaired the production of MMP-1 induced by PDGF-BB (Fig. 5C ).
The activation of ERK1/2 has been shown to partially depend on the generation of ROS in native LDL-stimulated human umbilical vein SMCs [34] . Our recent report showed that oxLDL induced the generation of ROS in rat mesangial cells [35] . However, we confirmed that although oxLDL stimulated the generation of ROS in hCSMCs, inhibition of the ROS generation by the antioxidant N-acetylcysteine had no effect on the oxLDL-induced activation of ERK1/2 or production of MMP-1 (Fig. 6 ).
We further examined whether oxidized lipids, such as 4-HNE and oxysterols, are involved in the production of MMP-1 in hCSMCs. The results shown in Fig. 7A indicate that stimulation with 4-HNE (2-20 μM) dose-dependently induced the production of MMP-1 (for 24 h) with the preceding phosphorylation of ERK1/2 (for 10 min). However, 7-ketocholesterol (10 μM), 25-hydroxycholesterol (10 μM), 13-hydroxyoctadecadienoic acid (5 μM), or lysophosphatidylcholine (5 μM) had no effect on the production of MMP-1 (Fig. 7D ). Pretreatment with PD98059 (2-10 μM) dose-dependently suppressed the 4-HNE (10 μM)-induced production of MMP-1 as well as phosphorylation of ERK1/2 ( Fig. 7B and C) . In addition to oxLDL, 4-HNE (10 μM, for 10 min) induced tyrosine phosphorylation of PDGFR-β, which was significantly Fig. 3 . Phosphorylation of PDGFR-β by oxLDL, and inhibition of the phosphorylation by genistein. (A) hCSMCs were stimulated with oxLDL (50 μg/ml) for the indicated periods. PDGFR-β (PDGFR) and its tyrosinephosphorylated form (p-PDGFR) in the cells were detected by the immunoprecipitation of PDGFR-β followed by immunoblotting. (B) hCSMCs were stimulated with or without oxLDL (50 μg/ml) or native LDL (nLDL, 50 μg/ml) for 10 min. PDGFR and p-PDGFR in the cells were detected as in A. (C) hCSMCs were treated with or without genistein (20 or 50 μM) for 1 h, and stimulated with (+) or without (−) oxLDL (50 μg/ml) for 10 min. PDGFR and p-PDGFR in the cells were detected as in A. The degree of the phosphorylation of PDGFR was estimated by measuring the density of the PDGFR and p-PDGFR bands (mean ± SEM). inhibited by pretreatment with genistein (20 μM) and AG1295 (100 μM) (Fig. 8A) . Under the conditions, genistein (10 or 20 μM) and AG1295 (20-100 μM) prevented the 4-HNE (10 μM)-induced production of MMP-1 in a dosedependent manner (Fig. 8B and C) . We confirmed that 6 . Effects of N-acetylcysteine on the oxLDL-induced generation of ROS, activation of ERK1/2, and production of MMP-1. (A) hCSMCs were treated with or without N-acetylcysteine (NAC, 10 mM) for 24 h and washed. The cells were treated with DCFH diacetate (20 μM) for 30 min. After being washed, cells were stimulated with or without oxLDL (50 μg/ml) for 30 min. The fluorescence of 2′,7′-dichlorofluorescein resulting from DCFH oxidation was measured. (B) hCSMCs were treated with or without NAC (5 or 10 mM) for 24 h. After being washed, the cells were stimulated with or without oxLDL (50 μg/ml) for 10 min for the detection of phosphorylated ERK1/2 (p-ERK1/2) or for 24 h for the detection of MMP-1. ERK1/2 and p-ERK1/2 in the cells and MMP-1 in the extracellular medium were analyzed by immunoblotting. Fig. 4 . Inhibition of the oxLDL-induced production of MMP-1 by genistein and AG1295. (A) hCSMCs were treated with or without genistein (20 or 50 μM) for 1 h, and stimulated with (+) or without (−) oxLDL (50 μg/ml) for 24 h. MMP-1 in the extracellular medium was analyzed by immunoblotting. The amount of MMP-1 was estimated by measuring the density of the MMP-1 band (mean ± SEM). (B) hCSMCs were treated with or without genistein (10 or 20 μM) for 1 h, and stimulated with (+) or without (−) oxLDL (50 μg/ml) or phorbol 12-myristate 13-acetate (PMA, 100 nM) for 10 min. ERK1/2 and its phosphorylated form (p-ERK1/2) in the cells were analyzed by immunoblotting. (C) hCSMCs were treated with or without AG1295 (20-100 μM) for 1 h, and stimulated with (+) or without (−) oxLDL (50 μg/ml) for 24 h. (D) hCSMCs were treated with or without AG1478 (250 or 500 nM) for 1 h, and stimulated with (+) or without (−) oxLDL (50 μg/ml) for 24 h. AG1295 (20-100 μM) suppressed the production of MMP-1 induced by PDGF-BB (10 ng/ml) (Fig. 8D ).
Discussion
The formation of atherosclerotic lesions is a complex process, which is mediated by numerous cellular responses in SMCs and macrophages stimulated with cytokines, oxLDL, or bioactive oxidized lipids, such as 4-HNE and oxysterols. Among the cellular responses, the production of collagenases including MMP-1 is a critical event responsible for the progression of atherosclerosis, because collagenases are the only MMPs that can catalyze the degradation of native collagen, a major structural component of atherosclerotic lesions, being involved in the migration of vascular SMCs into the intima and the rupture of plaques. The expression of MMP-1 is increased in human atherosclerotic plaques, where SMCs [14, 15] and macrophages [14, 16] are colocalized, although it is unclear whether MMP-1 is produced by the atheroma-associated cells in response to oxLDL and bioactive oxidized lipids. The present study demonstrated that oxLDL or 4-HNE accelerated the production of MMP-1 in hCSMCs. Thus, it is possible that the activation of SMCs by oxLDL and 4-HNE is involved in the production of MMP-1 at atherosclerotic lesions.
With regard to the mechanisms responsible for the production of MMP-1 elicited by oxLDL and 4-HNE, we showed here that they induced the activation of ERK1/2, inhibition of which resulted in a suppression of MMP-1 production, suggesting the involvement of ERK1/2 in the production of MMP-1. This is consistent with the notion reported recently [36] . The activation of ERK1/2 is triggered by the stimulation of several types of receptors. PDGFR-β has been shown to be one of the receptors involved in the activation of ERK1/2 in SMCs [29, 30] . The present study demonstrated that stimulation of hCSMCs with oxLDL and 4-HNE induced tyrosine phosphorylation of PDGFR-β. Furthermore, inhibition by genistein of the phosphorylation of PDGFR-β occurred in parallel with a suppression of ERK1/2 activation in oxLDL-stimulated hCSMCs. It is possible that the activation of PDGFR-β is related to the activation of ERK1/2, as suggested in guinea-pig airway [29] and chick gizzard [30] SMCs. oxLDL has been shown to activate PDGFR-β in an early phase within 1 h that is independent of ROS and in a late phase at 5 h that is dependent on ROS in rabbit arterial SMCs [31] . Consistent with the early phase, we demonstrated that oxLDL and 4-HNE induced tyrosine phosphorylation of PDGFR-β relatively quickly (within 20 min) in hCSMCs. In the present study, we found that under conditions where the oxLDL-and 4-HNE-induced activation of PDGFR-β was suppressed by AG1295 and genistein, the accelerated production of MMP-1 was significantly prevented. Our results suggest that the activation of PDGFR-β is involved in the production of MMP-1 in response to oxLDL and 4-HNE. It has been proposed that the activation by oxLDL of PDGFR-β is ascribable to the direct interaction of the receptor with the 4-HNE that diffuses from oxLDL particles to plasma membranes to form adducts with the receptor [31] . In addition to PDGFR-β, epidermal growth factor receptor is reported to be activated by oxLDL in bovine aortic SMCs and human CRL-1998 endothelial cells [37] . However, the contribution of epidermal growth factor receptor seems unlikely, because the oxLDLaccelerated production of MMP-1 in hCSMCs was not affected by AG1478, an inhibitor of the receptor. Based on the present findings, we suggest that the oxLDL-and 4-HNE-induced activation of PDGFR-β is involved, at least in part, in the initiation of intracellular signaling leading to the production of MMP-1.
A previous report showed that oxLDL induces the secretion of PDGF-AA in canine SMCs prepared from prosthetic vascular grafts [33] . This finding raises a possibility that PDGF generated endogenously might be involved in the oxLDL-induced production of MMP-1. Under our experimental conditions, however, oxLDL seems to scarcely promote the expression of PDGF-AA mRNA or PDGF-BB mRNA despite an increase in MMP-1 mRNA. Similarly, in canine aortic SMCs, oxLDL does not induce the production of PDGF-AA [33] . Furthermore, the oxLDL-induced production of MMP-1 was not affected under conditions where hCSMCs were stimulated with oxLDL in the presence of anti-PDGF antibodies. Considering these findings, it seems unlikely that autocrine effects of PDGF generated endogenously are involved in the oxLDL-induced production of MMP-1 in hCSMCs.
In summary, we demonstrated here that stimulation of hCSMCs with oxLDL and 4-HNE induced the production of MMP-1 with the preceding phosphorylation of PDGFR-β and ERK1/2. The present results suggest that the acceleration of MMP-1 production depends on the activation of PDGFR-β and ERK1/2.
